Tvardi Therapeutics(DE:69C)
€1.10-0.07 (-5.98%)
DE:69C
Tvardi Therapeutics ownership
€1.10
At close:-0.07 (-5.98%)
Tvardi Therapeutics (69C) Ownership - Who Owns Tvardi Therapeutics?
1 Followers
Tvardi Therapeutics (69C) Ownership Overview
- 3.36% Insiders
- 4.90% Mutual Funds
- 2.25% Other Institutional Investors
- 2.58% ETFs
- 86.91% Public Companies and Individual Investors
The ownership structure of Tvardi Therapeutics (DE:69C) stock is a mix of institutional, retail, and individual investors. Approximately 9.73% of the company’s stock is owned by Institutional Investors, 3.36% is owned by Insiders, and 86.91% is owned by Public Companies and Individual Investors.
The ownership structure of Tvardi Therapeutics (DE:69C) stock is a mix of institutional, retail, and individual investors. Approximately 9.73% of the company’s stock is owned by Institutional Investors, 3.36% is owned by Insiders, and 86.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| David Gerald Greenspan | 704,118 | Institution | 5.28% | 856,207 |
| Vanguard | 344,382 | Institution | 2.58% | 418,769 |
| Vanguard Index Funds | 344,382 | Institution | 2.58% | 418,769 |
| Wallace L Jr Hall | 246,756 | Insider | 1.85% | 300,055 |
| Susan Ph.d. Shiff | 202,085 | Insider | 1.51% | 245,735 |
| Fidelity Concord Street Trust | 102,157 | Institution | 0.77% | 124,223 |
| Fidelity Commonwealth Trust Ii | 95,825 | Institution | 0.72% | 116,523 |
| BlackRock, Inc. | 95,478 | Institution | 0.72% | 116,101 |
| Tiaa-cref Funds | 91,756 | Institution | 0.69% | 111,575 |
| Andrew J.M. Spokes | 21,438 | Institution | 0.16% | 26,069 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 344,382 | Institution | 2.58% | 418,769 |
| Fidelity Concord Street Trust | 102,157 | Institution | 0.77% | 124,223 |
| Fidelity Commonwealth Trust Ii | 95,825 | Institution | 0.72% | 116,523 |
| Tiaa-cref Funds | 91,756 | Institution | 0.69% | 111,575 |
| Northern Funds | 12,501 | Institution | 0.09% | 15,201 |
| Victory Portfolios Iii | 4,696 | Institution | 0.04% | 5,710 |
| Bridge Builder Trust | 2,168 | Institution | 0.02% | 2,636 |
| Advisors' Inner Circle Iii | 36 | Institution | <0.01% | 44 |
FAQ
Who Owns Tvardi Therapeutics (DE:69C)?
According to the latest TipRanks data, approximately 9.73% of the company's stock is held by institutional investors, 3.36% is held by insiders, and 86.91% is held by public companies and individual investors.
What percentage of Tvardi Therapeutics (DE:69C) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.73% of Tvardi Therapeutics (DE:69C) stock is held by institutional investors: 4.90% by mutual funds, 2.58% by ETFs and 2.25% by other institutional investors.
What percentage of Tvardi Therapeutics (DE:69C) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.91% of Tvardi Therapeutics (DE:69C) stock is held by public companies and individual investors.
Who owns the most shares of Tvardi Therapeutics (DE:69C)?
David Gerald Greenspan owns the most shares of Tvardi Therapeutics (DE:69C).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
